Medicine recalls
|
| |
| Australia: Recall: Apo-Perindopril Arginine: Update – additional batches being recalled |
| |
The Therapeutic Goods Administration (TGA) is advising consumers and healthcare professionals that Apotex, in consultation with the TGA, is recalling eight additional batches of Apo-Perindopril Arginine. The full list of affected products and batch numbers are:
- Apo-Perindopril Arginine 2.5mg: NC6619 (EXP 02/2020), NC6620 (EXP 02/2020), MX1699 (EXP 05/2019) and MX1697 (EXP 05/2019)
- Apo-Perindopril Arginine 5mg: NC6671 (EXP 03/2020), NC6670 (EXP 03/2020), MX1702 (EXP 05/2019) and NC6672 (EXP 03/2020)
- Apo-Perindopril Arginine 10mg: MX1705 (EXP 05/2019), MX1703 (EXP 05/2019), MX1704 (EXP 05/2019)
All other information and advice provided previously on 9 Nov 2017 remains accurate and appropriate.
Please refer to the following website in TGA for details:
http://www.tga.gov.au/alert/apo-perindopril-arginine
In Hong Kong, the above products are not registered pharmaceutical products. Related news was previously issued by TGA, and was posted on the Drug Office website on 10 Nov 2017.
Ends/Friday, Nov 17, 2017
Issued at HKT 16:00
|
| |
|
